Effect of antenatal prophylactic betamethasone injection on neonatal respiratory distress syndrome reduction in multifetal pregnancies

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180227038879N1

Enrollment

140

Registered

2018-03-10

Start date

2018-02-05

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

?????? ??? ?????. Supervision of multiparity pregnancy

Interventions

Intervention 1: Intervention group 1: Betamethasone ampoule (manufactured in Iran), 12 mg(Intramuscular injection) per 24 hours, will be injected into two doses between the weeks of gestation 28-26.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Multiple pregnancy less than 28 weeks

Exclusion criteria

Exclusion criteria: Dissatisfaction patient to participate in this study. Motherhood disease that limits the administration of corticosteroids. Multifetal pregnancies that has another risk factor for early childbirth.

Design outcomes

Primary

Measure	Time frame
Neonatal respiratory distress syndrome. Timepoint: Immediately after birth. Method of measurement: Newborn clinical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Abbasalizadeh

Tabriz University of Medical Sciences

lahroudin@gmail.com+98 41 3553 9161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 20, 2026